XML 16 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Income Statement [Abstract]        
Net sales $ 178,229 $ 147,906 $ 715,631 $ 714,127
Cost of sales 118,820 144,106 430,134 475,303
Gross profit 59,409 3,800 285,497 238,824
Operating expenses:        
Selling expense 49,871 60,273 179,851 212,822
General and administrative expense 18,870 18,238 48,626 48,918
Research and development expense 7,689 7,978 22,435 22,381
Total operating expenses 76,430 86,489 250,912 284,121
Income (loss) from operations (17,021) (82,689) 34,585 (45,297)
Other income (expense), net (3,095) (3,359) 934 (4,246)
Income (loss) before income taxes (20,116) (86,048) 35,519 (49,543)
Income tax provision 1,037 750 4,941 2,654
Net income (loss) (21,153) (86,798) 30,578 (52,197)
Dividends on convertible preferred stock (1,766) (2,414) (3,332) (7,664)
Net income (loss) allocable to common shareholders $ (22,919) $ (89,212) $ 27,246 $ (59,861)
Earnings (loss) per common share:        
Basic $ (0.32) $ (1.33) $ 0.38 $ (0.91)
Diluted $ (0.32) $ (1.33) $ 0.36 $ (0.91)
Weighted-average common shares outstanding:        
Basic 72,649 67,162 71,613 65,740
Diluted 72,649 67,162 86,870 65,740